Top Glove Corporation Bhd.
0.28
SGD
-0.01
(-3.51%)
ISIN
MYL7113OO003
Return %
Stock
S&P 500
1Y
34.15
14.20
3Y
30.95
81.12
5Y
-69.10
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Wee Chai Lim
- Full Time Employees
- 10,600
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Top Glove Tower Shah Alam SE Malaysia 40170
- IPO Date
- Mar 1, 2001
- Website
- topglove.com
- Similar Companies
- Business
- Top Glove Corporation Bhd is a Malaysian manufacturer specializing in rubber gloves and related healthcare products. It produces a comprehensive range of gloves including latex, nitrile, vinyl examination gloves; surgical gloves; cleanroom gloves; household gloves; industrial gloves; cast polyethylene (CPE) gloves; and thermoplastic elastomer (TPE) gloves. The company also offers non-glove products such as face masks, dental dams, exercise bands, condoms, hand sanitizers, and other personal and home care items. Its manufacturing operations are primarily located in Malaysia, Thailand, and Vietnam, with marketing offices strategically placed in key global markets including the United States, Germany, Brazil, and China. Founded in 1991 and headquartered in Shah Alam, Malaysia, Top Glove serves over 2,000 customers across 195 countries worldwide. In the last 1-2 years, Top Glove has undergone significant strategic developments. It has formed a joint venture with Tronex (Asia) Limited and Polywel International Trade Company to expand into High Density Polyethylene (HDPE) glove production, diversifying its product portfolio. The company reinstated dividend payouts in FY2025, signaling a return to financial health after a period of losses, with a net profit of RM109 million in FY2025 driven by increased export volumes and operational efficiencies. Top Glove is focused on expanding its footprint in the U.S. market despite rising competition, leveraging improved cost structures and a more level playing field following tariff changes. It continues to invest in advanced glove manufacturing technology and sustainability initiatives, recently earning an 'AA' rating in MSCI ESG assessments. The company maintains a strong emphasis on research and development to innovate and meet evolving healthcare and industrial demand. Top Glove’s products cater to diverse sectors including healthcare, food handling, cleanroom environments, industrial applications, and personal protection markets. The company leverages state-of-the-art automated production lines and robust quality control systems to ensure product consistency and compliance with international standards such as ASTM, EN, and ISO. Market expansion strategies are supported by improved financial metrics—lower debt-to-asset ratios and cost control measures—that enhance resilience in a competitive global glove market. Top Glove’s strategic focus also includes responding to industry trends like the U.S. tariff hikes on Chinese gloves, positioning itself advantageously as a Southeast Asian manufacturer. Overall, Top Glove is positioned as the world’s largest glove manufacturer with a broad product range, global distribution reach, and ongoing growth initiatives that underscore its leadership in the healthcare and protective glove industries. Its operational scale, product innovation, and strategic partnerships drive its competitive standing and future growth potential.
Company News
Top Glove Co. Bhd. (OTCMKTS:TGLVY) Trading Up 15.3% – Time to Buy?
Top Glove Corp: Waiting for a good time to invest in the U.S.
Trade Winds Turning: 3 Stocks Poised to Gain from Biden's China Tariffs
7 Hot Penny Stocks That Could See Outsized Gains
Top Glove: Value Emerging From The Storm
Top Glove shelves HK listing as Ukraine war roils markets
Shares of the world's largest medical glove maker have erased most Covid gains
Top Glove warns of weak demand as profit slumps
Top Glove shareholders approve $473-million Hong Kong listing plan